Quality assurance of I-125 seeds for prostate brachytherapy using an imaging plate

被引:11
|
作者
Furutani, Shunsuke
Saze, Takuya
Ikushima, Hitoshi
Oita, Masataka
Ozaki, Kyousuke
Kishida, Yoshlomi
Takegawa, Yoshihiro
Nishitani, Hiromu
机构
[1] Univ Tokushima, Dept Radiol, Tokushima 7708503, Japan
[2] Univ Tokushima, Radiosotope Res Ctr, Tokushima 7708503, Japan
[3] Univ Tokushima, Dept Hlth Sci, Tokushima 7708503, Japan
关键词
I-125; seed; cartridge; imaging plate; quality assurance; prostate brachytherapy;
D O I
10.1016/j.ijrobp.2006.05.052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: OncoSeed is delivered in a sterile environment in the form of a cartridge, so it is impractical to resterilize and reload seeds after calibration. We investigated a new method using an imaging plate dosimetry system to characterize all seeds in the OncoSeed cartridge in a sterile environment. Methods and Materials: Seeds within the cartridge were placed on an imaging plate, and the imaging plate irradiated. To remove scatter radiation, and improve spatial resolution of seed images, we used X-ray parallel cross grids. The irradiated imaging plate was scanned using a Bio-imaging Analyzer System, and radioactivity intensities of seed images were given in counts. Counts could be translated to profiles, and each seed within the cartridge was analyzed. Results: Results showed a good correlation between counts and total radioactivity of the seeds within the cartridge. Thus, using a least-squares line, it was possible to characterize a cartridge with unknown apparent activity. By analyzing the profiles, it was possible not only to detect a miscalibrated seed in the cartridge from its relative difference in counts, but also to identify its position in the cartridge. No significant changes in counts were seen between sterile and nonsterile environments. Conclusion: Using an imaging plate dosimetry system, all seeds in a cartridge could be characterized in a sterile environment. (c) 2006 Elsevier Inc.
引用
收藏
页码:603 / 609
页数:7
相关论文
共 50 条
  • [21] DOSIMETRIC COMPARISON BETWEEN LINKED AND STRAND SEEDS FOR I-125 PERMANENT SEED PROSTATE BRACHYTHERAPY
    Jakstas, Karolis
    Sniureviciute, Migle
    MEDICAL PHYSICS IN THE BALTIC STATES, 2010, (02): : 112 - +
  • [22] Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer
    Polders, Daniel L.
    Steggerda, Marcel
    Van Herk, Marcel
    Nichol, Kiri
    Witteveen, Thelma
    Moonen, Luc
    Nijkamp, Jasper
    Van der Heide, Uulke A.
    ACTA ONCOLOGICA, 2015, 54 (06) : 839 - 846
  • [23] Physical and technical quality assurance measures in interstitial brachytherapy of the prostate with iodine-125 seeds
    Kaulich, TW
    Lamprecht, U
    Paulsen, F
    Lorenz, J
    Maurer, U
    Loeser, W
    Bichler, KH
    Nüsslin, F
    Bamberg, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 65 - 65
  • [24] Seed displacements after permanent I-125 brachytherapy for prostate cancer - Comparison of seeds in different prostate areas
    Pinkawa, M.
    Gagel, B.
    Asadpour, B.
    Piroth, M. D.
    Klotz, J.
    Borchers, H.
    Jakse, G.
    Eble, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S347 - S347
  • [25] Quality of Life, 5 Years after I-125 Brachytherapy for Localised Prostate Cancer
    Witteveen, T. H.
    Al-Qaisieh, B.
    Bottomley, D.
    Carey, B.
    Smith, J.
    Bownes, P.
    Henry, A.
    CLINICAL ONCOLOGY, 2009, 21 (03) : 249 - 249
  • [26] Quality of life, five years after I-125 brachytherapy for localised prostate cancer
    Witteveen, T. H.
    Al-Qaisieh, B.
    Bottomley, D.
    Franks, K.
    Carey, B.
    Smith, J.
    Bownes, P.
    Henry, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 411 - 411
  • [27] Brachytherapy dose inhomogeneity correction using I-125 seeds in the management of carcinomas of the nasopharynx
    Sadeghi, KA
    Bice, W
    Prestidge, BR
    IRPA9 - 1996 INTERNATIONAL CONGRESS ON RADIATION PROTECTION / NINTH INTERNATIONAL CONGRESS OF THE INTERNATIONAL RADIATION PROTECTION ASSOCIATION, PROCEEDINGS, VOL 3, 1996, : C522 - C522
  • [28] Quantitative Evaluation of Neurovascular Bundle Doses in Low-Dose-Rate Prostate Brachytherapy Using I-125 Seeds
    Sindhwani, R. G.
    Algan, O.
    Thompson, S.
    Mellis, A.
    Sindhwani, P.
    Ahmad, S.
    Ali, I.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S388 - S388
  • [29] Quality of Life, 5 Years after I-125 Brachytherapy for Localized Prostate Cancer
    Franks, K. N.
    Witteveen, T. H.
    Al-Qaisieh, B. B.
    Bottomley, D. M.
    Smith, J.
    Carey, B. M.
    Bownes, P.
    Henry, A. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S155 - S155
  • [30] Influence of primary quality improvement and assurance meaures on total cost of treatment - Implantation of I-125 seeds in localized prostate cancer
    Zimmerman, JS
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 120 - 120